Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Lung Neoplasms 8Prostatic Neoplasms 4Uterine Cervical Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma 2Hematologic Neoplasms 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Anus Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Smoking 1Recurrence 1Pancreatic Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Nose Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Neoplasm Metastasis 1Myocarditis 1Metastatic Solid Tumors 1Melanoma 1Lymphoproliferative Disorders 1

Interventions

Cisplatin 32Radiotherapy, Intensity-Modulated 21Magnetic Resonance Spectroscopy 21Radiotherapy 16Specimen Handling 15Radiation 14Carboplatin 14pembrolizumab 13Platinum 121,2-diaminocyclohexaneplatinum II citrate 11Paclitaxel 8Chemoradiotherapy 7Biopsy 7Taxes 6Surveys and Questionnaires 6Cetuximab 6Nivolumab 5Surgical Procedures, Operative 4Observation 4Fluorodeoxyglucose F18 4Drug Therapy 4Docetaxel 4durvalumab 3(225)Ac-DOTA-c(RGDyK) 3toripalimab 2cemiplimab 2atezolizumab 2aldesleukin 2X-Rays 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Tomography, X-Ray Computed × 1 year × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡